Genenta Science (Nasdaq: GNTA) Email Format
Biotechnology ResearchLombardy, Italy11-50 Employees
Genenta Science, based in Milan, Italy, operates in biotechnology research and has a small to mid-sized workforce. It trades on Nasdaq as GNTA and is slated to rename to Saentra Forge, with the ticker SAEN awaiting effectiveness. The company is described as a next-generation strategic consolidator focused on privately held specialized companies in Italian national security regulated sectors, including cybersecurity, defense, aerospace, and biotechnology/biosecurity. As part of its consolidation strategy, Genenta Science S.r.l. completed the acquisition of ATC S.r.l., a precision weapons manufacturer. The organization has pursued collaborations with other biotechnology and technology providers as part of its broader activity in regulated sectors in Italy.